M V25 (Hydrochlorothiazide and valsartan 25 mg / 320 mg)

Pill imprint M V25 has been identified as Hydrochlorothiazide and valsartan 25 mg / 320 mg.

Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 25 mg / 320 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M V25

Hydrochlorothiazide and valsartan 25 mg / 320 mg M V25
Hydrochlorothiazide and valsartan
Imprint:
M
V25
Strength:
25 mg / 320 mg
Color:
Beige
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-6325
Inactive Ingredients:
silicon dioxide
crospovidone
hypromelloses
lactose monohydrate
FD&C Blue No. 2
magnesium stearate
microcrystalline cellulose
FD&C Yellow No. 6
polydextrose
polyethylene glycol
povidone
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)